Nanosuspension-Based Dissolving Microneedle Arrays for Intradermal Delivery of Curcumin

被引:122
作者
Abdelghany, Sharif [1 ,2 ]
Tekko, Ismaiel A. [1 ,3 ]
Vora, Lalitkumar [1 ]
Larraneta, Eneko [1 ]
Permana, Andi Dian [1 ,4 ]
Donnelly, Ryan F. [1 ]
机构
[1] Queens Univ Belfast, Med Biol Ctr, Sch Pharm, 97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland
[2] Univ Jordan, Sch Pharm, Amman 11942, Jordan
[3] Aleppo Univ, Fac Pharm, Dept Pharmaceut & Pharmaceut Technol, POB 12212, Aleppo, Syria
[4] Hasanuddin Univ, Fac Pharm, Dept Pharmaceut, Makassar 90234, Indonesia
基金
英国惠康基金;
关键词
curcumin; dissolving microneedles; intradermal; poly(vinylalcohol); nanosuspension; I CLINICAL-TRIAL; TRANSDERMAL DELIVERY; SKIN; NANOPARTICLES; PENETRATION; BIOMARKERS; HYDROGELS; MODEL; TOOL;
D O I
10.3390/pharmaceutics11070308
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The objective of this study was to evaluate the intradermal delivery of curcumin utilising poly(vinylalcohol) (PVA)-based microneedles loaded with curcumin nanosuspension (CU-NS). Nanoprecipitation was used to formulate the CU-NS which was then incorporated into PVA microneedles arrays consisting of 11 x 11 microneedles of conical shape, measuring 900 mu m in height and with 300 mu m base diameter. The nanosuspension particle size was 520 +/- 40 nm, with a polydispersity of 0.27 +/- 0.02 using sodium lauryl sulfate (SLS) as a stabiliser. In vitro dissolution studies in 10% w/v Tween 80 showed that the CU-NS dissolved significantly faster than unmodified curcumin powder, with 34% released from the CU-NS, compared to 16% from the curcumin powder after 48 h. The CU-NS-loaded microneedles (CU-MN) were able to withstand a compression force of 32 N for 30 s. Moreover, these microneedles were able to penetrate excised neonatal porcine skin to a depth of 500 mu m, dissolved completely in the skin within 60 min. After CU-MN dissolution, the drug diffused from the application site and migrated through the skin layers down to 2300 mu m, significantly more than observed with topical application of CU-NS. This suggest that the fabricated microneedles with the incorporated CU-NS could enhance the intradermal delivery of curcumin.
引用
收藏
页数:13
相关论文
共 40 条
[31]
Phase I clinical trial of oral curcumin: Biomarkers of systemic activity and compliance [J].
Sharma, RA ;
Euden, SA ;
Platton, SL ;
Cooke, DN ;
Shafayat, A ;
Hewitt, HR ;
Marczylo, TH ;
Morgan, B ;
Hemingway, D ;
Plummer, SM ;
Pirmohamed, M ;
Gescher, AJ ;
Steward, WP .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6847-6854
[32]
Singh Thakur R R, 2010, Recent Pat Drug Deliv Formul, V4, P1
[33]
Topical Curcumin-Based CreamIs Equivalent to Dietary Curcumin in a Skin Cancer Model [J].
Sonavane, Kunal ;
Phillips, Jeffrey ;
Ekshyyan, Oleksandr ;
Moore-Medlin, Tara ;
Gill, Jennifer Roberts ;
Rong, Xiaohua ;
Lakshmaiah, Raghunatha Reddy ;
Abreo, Fleurette ;
Boudreaux, Douglas ;
Clifford, John L. ;
Nathan, Cherie-Ann O. .
JOURNAL OF SKIN CANCER, 2012, 2012
[34]
Integrated oral bioavailability projection using in vitro screening data as a selection tool in drug discovery [J].
Stoner, CL ;
Cleton, A ;
Johnson, K ;
Oh, DM ;
Hallak, H ;
Brodfuehrer, J ;
Surendran, N ;
Han, HK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 269 (01) :241-249
[35]
Minimally invasive protein delivery with rapidly dissolving polymer microneedles [J].
Sullivan, Sean P. ;
Murthy, Niren ;
Prausnitz, Mark R. .
ADVANCED MATERIALS, 2008, 20 (05) :933-+
[36]
The immunology of the porcine skin and its value as a model for human skin [J].
Surnmerfield, Artur ;
Meurens, Francois ;
Ricklin, Meret E. .
MOLECULAR IMMUNOLOGY, 2015, 66 (01) :14-21
[37]
Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo [J].
Vicente-Perez, Eva M. ;
Larraneta, Eneko ;
McCrudden, Maeliosa T. C. ;
Kissenpfennig, Adrien ;
Hegarty, Shauna ;
McCarthy, Helen O. ;
Donnelly, Ryan F. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2017, 117 :400-407
[38]
Vora Lalit K, 2018, J Interdiscip Nanomed, V3, P89, DOI 10.1002/jin2.41
[39]
Novel bilayer dissolving microneedle arrays with concentrated PLGA nanomicroparticles for targeted intradermal delivery: Proof of concept [J].
Vora, Lalit K. ;
Donnelly, Ryan F. ;
Larraneta, Eneko ;
Gonzalez-Vazquez, Patricia ;
Thakur, Raghu Raj Singh ;
Vavia, Pradeep R. .
JOURNAL OF CONTROLLED RELEASE, 2017, 265 :93-101
[40]
Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles [J].
Zhang, Wei ;
Gao, Jing ;
Zhu, Quangang ;
Zhang, Min ;
Ding, Xueying ;
Wang, Xiaoyu ;
Hou, Xuemei ;
Fan, Wei ;
Ding, Baoyue ;
Wu, Xin ;
Wang, Xiying ;
Gao, Shen .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 402 (1-2) :205-212